Entry 0012Rev 1.0Synthetic heptapeptide

Semax

Met-Glu-His-Phe-Pro-Gly-Pro · C37H51N9O10S

Reviewed

2 Nov 2026

Scientific editor

[Name, PhD]

References

7 sources

Semax is a seven-residue peptide made from residues 4 to 7 of ACTH, the pituitary stress hormone, with the same Pro-Gly-Pro tail used in Selank. It was first described in the scientific literature in 1991.1

It is a prescription drug in Russia and on the Russian government's list of vital and essential medicines. It has not been evaluated or approved in the UK, the EU or the US.2

Residues

7

Avg mass

813.9 g/mol

First described

1991

Licensed

Russia only

01

Identity

Fig. 1 · Sequence map. ACTH positions 4–7, then the added Pro-Gly-Pro tail, shaded.

Value
DeveloperInstitute of Molecular Genetics, Russian Academy of Sciences
Based onACTH (4–7) plus Pro-Gly-Pro
FormulaC37H51N9O10S
Avg mass813.9 g/mol
CAS80714-61-0
02

History

  1. First described, with its breakdown by rat blood enzymes.1

  2. Shown to inhibit enkephalin-degrading enzymes in human serum.3

  3. Raises BDNF and its receptor in rat hippocampus.4

  4. Added to Russia's list of vital and essential drugs.2

  5. Proposed to act at melanocortin receptors.5

03

What the studies measured

AreaModelWhat was measuredSource
StabilityRat blood enzymesHow fast the peptide is broken down[1]
EnzymesHuman serum in vitroInhibition of enkephalin-degrading enzymes[3]
Brain chemistryRatsBDNF and TrkB in the hippocampus[4]
ReceptorsReview of binding dataMelanocortin receptor antagonism[5]
NeurotransmittersRats and miceDopamine and serotonin systems[6]
04

Regulatory and sport status

WhereStatus
RussiaPrescription medicine; on the list of vital and essential drugs since 2011.2
UK, EU, USNot evaluated or approved. Not a controlled drug in the UK. May not be supplied or promoted for human use.
SportNot named on the WADA list. Because it has approval in Russia, class S0 may not apply; athletes should check with their anti-doping body.7
05

Open questions

  1. Clinical evidence that meets Western standards. The Russian clinical claims rest on older, smaller studies.
  2. Mechanism. Enzyme inhibition, BDNF and melanocortin receptor effects have all been proposed.
  3. Independent replication outside Russian institutes.
06

Common questions

What is Semax?

A seven-residue peptide made from part of ACTH, a pituitary hormone, with a Pro-Gly-Pro tail added for stability.

Is Semax approved anywhere?

In Russia, where it is a prescription drug. Not in the UK, the EU or the US.

How is it related to Selank?

Same institute, same Pro-Gly-Pro tail. Selank is built on tuftsin instead of ACTH.

Is Semax banned in sport?

It is not named on the WADA list. Athletes should check with their anti-doping body.

Does Semax act like ACTH?

The fragment it uses does not include the part of ACTH that drives cortisol release, and it is not reported to raise cortisol.

—

See also

07

References

  1. Potaman VN, et al. [First description of Semax and its degradation by rat blood enzymes]. Biochem Biophys Res Commun. 1991;176(2):741–746. PMID 1851003
  2. Wikipedia. Semax, citing the Russian List of Vital and Essential Drugs (7 December 2011), checked 2 Nov 2026.
  3. Kost NV, et al. Semax and selank inhibit the enkephalin-degrading enzymes from human serum. Bioorg Khim. 2001;27(3):180–183. PMID 11443939
  4. Dolotov OV, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54–60. PMID 16996037
  5. Bertolini A, et al. [Semax as a melanocortin receptor antagonist]. Eur J Pharmacol. 2012;679(1–3):1–8. PMID 22293371
  6. Eremin KO, et al. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005;30(12):1493–1500. PMID 16362768
  7. World Anti-Doping Agency. The 2026 Prohibited List. wada-ama.org

Peptidarium Library. Semax (entry 0012), revision 1.0, 2 November 2026. peptidarium.com/library/semax

08

Revision history

RevDateChangeBy
1.02 Nov 2026Entry created.[Scientific editor]

Spotted an error or a missing paper? Send a correction. Every change is logged here.